drug regulation

Showing 1 posts of 1 posts found.

NICE recommends daratumumab quadruplet for newly diagnosed multiple myeloma

October 8, 2026
NICE, Oncology, drug recommendation, drug regulation

NICE has published final draft guidance recommending daratumumab with bortezomib, lenalidomide and dexamethasone (D-VRd) for previously untreated adults with multiple …

The Gateway to Local Adoption Series

Latest content